Search Results - Tavag, Mrinalini

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    CbtA toxin of Escherichia coli inhibits cell division and cell elongation via direct and independent interactions with FtsZ and MreB

    CbtA toxin of Escherichia coli inhibits cell division and cell elongation via direct and independent interactions with FtsZ and MreB by Heller, Danielle M, Tavag, Mrinalini, Hochschild, Ann

    Published in PLoS genetics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period

    Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period by Hutton, David, Newman-Casey, Paula Anne, Tavag, Mrinalini, Zacks, David, Stein, Joshua

    Published in Health Affairs
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period

    Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period by Hutton, David, Newman-Casey, Paula Anne, Tavag, Mrinalini, Zacks, David, Stein, Joshua

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    UK-1 and structural analogs are potent inhibitors of hepatitis C virus replication

    UK-1 and structural analogs are potent inhibitors of hepatitis C virus replication by Ward, Dawn N., Talley, Daniel C., Tavag, Mrinalini, Menji, Samrawit, Schaughency, Paul, Baier, Andrea, Smith, Paul J.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis)

    Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis) by Stein, Joshua D, Newman-Casey, Paula Anne, Mrinalini, Tavag, Lee, Paul P, Hutton, David W

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: